3 July 2024
A Message from the Editor-in-Chief of Hematology Reports | Updated Impact Factor of 1.1

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
I am very glad to inform you that Hematology Reports (ISSN: 2038-8330) was awarded an increased Impact Factor of 1.1 in the 2023 Journal Citation Reports™ released by Clarivate. The new IF represents a 22.22% increase compared to our 2022 record of 0.9.
This remarkable increase in impact factor for Hematology Reports underscores the rigorous peer-review process and the high quality of scientific papers that have been published. It clearly demonstrates the important role that this journal has played and will continue to play in advancing scientific knowledge and providing a decision-support tool for the management of hematological malignancies.
I would like to commend our entire Editorial Board, including the Section Editors-in-Chief, the editors of Special Issues and Topical Collections, the Managing Editors, and Assistant Editors, as well as the external referees, and all the members of the Society of Hematologic Oncology Italy—SOHO Italy, for working tirelessly to attract, review, and publish the best scientific discoveries in Hematology Reports. I am grateful for their outstanding contributions to our journal.
My special thanks are also extended to the MPDI leadership for their excellent vision in guiding the robust development of our journal.
Dr. Claudio Cerchione
Editor-in-Chief of Hematology Reports